Publication date: Jul 04, 2025
A new study by University of Bath scientists has highlighted two new potential families of drug molecules that could open the door to new treatments for tuberculosis. Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis, is the second largest infectious killer globally after Covid-19 and causes 1. 3 million deaths annually. It is the leading cause of death in people who are HIV posit .. .
| Concepts | Keywords |
|---|---|
| Annually | Alpha |
| Hiv | Bacterium |
| Killer | Bath |
| Mycobacterium | Bind |
| Universitys | Called |
| Compounds | |
| Drug | |
| Enzyme | |
| Mcr | |
| Molecules | |
| Sciences | |
| Team | |
| Treatment | |
| Treatments | |
| Tuberculosis |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | cancers |
| pathway | KEGG | Prostate cancer |
| disease | MESH | prostate cancer |
| disease | IDO | protein |
| disease | MESH | Tuberculosis |
| pathway | KEGG | Tuberculosis |
| disease | MESH | Covid-19 |
| disease | MESH | causes |
| disease | MESH | cause of death |
| drug | DRUGBANK | Cholesterol |
| disease | MESH | infections |
| drug | DRUGBANK | Tropicamide |
Original Article
(Visited 5 times, 1 visits today)